%0 Journal Article
%T The safety and serious adverse events of approved ALK inhibitors in malignancies: a meta-analysis
%A Dantong Sun
%A Dong Liu
%A Helei Hou
%A Jing Cong
%A Jingjuan Zhu
%A Kewei Liu
%A Man Jiang
%A Na Zhou
%A Xiaochun Zhang
%J Archive of "Cancer Management and Research".
%D 2019
%R 10.2147/CMAR.S190098
%K ALK inhibitors
%K safety
%K serious adverse events
%K lung toxicity
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511621/